Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases.

Smith WM, Zhou XP, Kurose K, Gao X, Latif F, Kroll T, Sugano K, Cannistra SA, Clinton SK, Maher ER, Prior TW, Eng C.

Hum Genet. 2001 Aug;109(2):146-51.

PMID:
11511919
[PubMed - indexed for MEDLINE]
2.

Molecular events in follicular thyroid tumors.

Kroll TG.

Cancer Treat Res. 2004;122:85-105. Review.

PMID:
16209039
[PubMed - indexed for MEDLINE]
3.

Origin of renal cell carcinomas.

Valladares Ayerbes M, Aparicio Gallego G, Díaz Prado S, Jiménez Fonseca P, García Campelo R, Antón Aparicio LM.

Clin Transl Oncol. 2008 Nov;10(11):697-712. Review.

PMID:
19015066
[PubMed - indexed for MEDLINE]
4.

Energy balance and food intake: the role of PPARgamma gene polymorphisms.

Cecil JE, Watt P, Palmer CN, Hetherington M.

Physiol Behav. 2006 Jun 30;88(3):227-33. Epub 2006 Jun 13. Review.

PMID:
16777151
[PubMed - indexed for MEDLINE]
5.

A nuclear receptor in thyroid malignancy: is PAX8/PPARgamma the Holy Grail of follicular thyroid cancer?

Fuhrer D.

Eur J Endocrinol. 2001 May;144(5):453-6. Review. No abstract available.

PMID:
11331209
[PubMed - indexed for MEDLINE]
Free Article
6.

Pluripotent PPARgamma polymorphisms.

Berg JP.

Eur J Endocrinol. 1999 Apr;140(4):293-5. Review. No abstract available.

PMID:
10097247
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk